Pregled bibliografske jedinice broj: 1117578
Evidence-Based Management of Chronic Urticaria in Children
Evidence-Based Management of Chronic Urticaria in Children // Pediatric Allergy, Immunology, and Pulmonology, 25 (2012), 4; 198-207 doi:10.1089/ped.2012.0149 (međunarodna recenzija, članak, stručni)
CROSBI ID: 1117578 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Evidence-Based Management of Chronic Urticaria in
Children
Autori
Pavić, Ivan ; Hojsak, Iva ; Čepin-Bogović, Jasna
Izvornik
Pediatric Allergy, Immunology, and Pulmonology (2151-321X) 25
(2012), 4;
198-207
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
chronic urticaria ; children
Sažetak
Chronic urticaria (CU) in children is a distressful disorder that can often be challenging to treat. Elimination or treatment of eliciting stimulus is the first step in the management of CU ; however, in the majority of cases, the cause remains unknown. According to currently available guidelines, H1- antihistamines are still first-line therapy for CU in children. Unfortunately, regularly approved doses relieve symptoms in <50% of patients, necessitating an up to 4-fold dose increase. However, in some patients, even high doses of H1-antihistamines fail to produce satisfactory results, leaving place for new therapeutic strategies in the treatment of CU ; first to add either leukotriene antagonist or H2-antihistamine. In severe, unresponsive cases, other therapeutic approaches should be considered. However, it is important to be familiar with the possible side effects, because some of these approaches imply off- label use of drugs. This review presents a summary of the evidence on the treatment of CU in pediatric patients available up to January 2012.
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus